Microglial cells kill prion-damaged neurons in vitro by a CD14-dependent process

Area of Science:

• Neuroscience
• Immunology
• Prion Diseases

Background:

• Prion diseases are associated with neuronal damage and death.
• Microglia are the primary immune cells in the central nervous system and play a role in neuroinflammation.
• The prion-derived peptide HuPrP106-126 is implicated in neuronal toxicity.

Purpose of the Study:

• To investigate the role of microglial cells in the killing of primary cortical neurons exposed to the prion-derived peptide HuPrP106-126.
• To determine the involvement of CD14 in the microglial-mediated neurotoxicity.
• To explore the potential therapeutic implications of targeting CD14.

Main Methods:

• Primary cortical neurons were exposed to the prion-derived peptide HuPrP106-126.
• Microglial cells were pre-treated with anti-CD14 antibodies or obtained from CD14 knockout mice.
• Human monocytes were used to assess CD14 epitope specificity in neurotoxicity.
• CD14-IgG chimeras were used to study binding interactions.

Main Results:

• Microglial cells were found to kill primary cortical neurons exposed to HuPrP106-126.
• Pre-treatment of microglia with anti-CD14 antibodies or the use of CD14 knockout microglia significantly increased neuronal survival.
• HuPrP106-126-damaged neurons selectively bound a CD14-IgG chimera.
• Monocyte-mediated killing of HuPrP106-126-damaged neurons was epitope-specific, with certain anti-CD14 monoclonal antibodies reducing toxicity.

Conclusions:

• CD14 plays a critical role in microglial-mediated neurotoxicity induced by the prion-derived peptide HuPrP106-126.
• Targeting CD14 on microglia and monocytes may represent a therapeutic strategy for prion-related neurodegenerative diseases.
• The findings highlight a specific mechanism of immune-mediated neuronal damage in prion diseases.